Shopping Cart
Remove All
Your shopping cart is currently empty
CE-224535 (PF-04905428) is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $118 | In Stock | In Stock | |
| 5 mg | $297 | In Stock | In Stock | |
| 10 mg | $419 | In Stock | In Stock | |
| 25 mg | $679 | In Stock | In Stock | |
| 50 mg | $953 | In Stock | In Stock | |
| 100 mg | $1,280 | In Stock | In Stock | |
| 200 mg | $1,730 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $247 | In Stock | In Stock |
| Description | CE-224535 (PF-04905428) is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies. |
| In vitro | CE-224535 reduces leukocyte secretion of IL-1 and IL-18, thereby providing a novel therapeutic approach for the treatment of rheumatoid arthritis[1]. |
| In vivo | In rats, CE-224535 exhibits a low CLp (11 mL/min/kg) and a large Vdss (7.6 L/kg), resulting in a half-life of 2.4 hours. Oral administration of CE-224535 (5 mg/kg) produces Cmax levels approximately 90 times higher than its IC90 in human blood (0.21 μg/mL or 0.44 μM)[2]. |
| Synonyms | PF-04905428 |
| Molecular Weight | 480.94 |
| Formula | C22H29ClN4O6 |
| Cas No. | 724424-43-5 |
| Smiles | COC[C@H](O)Cn1c(=O)cnn(-c2ccc(Cl)c(c2)C(=O)NCC2(O)CCCCCC2)c1=O |
| Relative Density. | 1.47g/cm3 |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 95 mg/mL (197.53 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10 mg/mL (20.79 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.